Frequency of tremor in people with multiple sclerosis: A systematic review and meta-analysis

Saeed Vaheb1, Danial Dehghani Firouzabadi2, Hamed Ghoshouni1

  • 1Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Abstract

Insights

Tremor affects one-third of people with multiple sclerosis (PwMS), impacting their quality of life. This systematic review highlights the need for targeted interventions to manage tremor in PwMS.

Area of Science:

  • Neurology
  • Neurodegenerative Diseases
  • Clinical Research

Background:

  • Multiple sclerosis (MS) is a chronic neurodegenerative disorder.
  • Tremor is a common and disabling symptom in people with MS (PwMS).
  • Previous estimates of tremor frequency in PwMS vary widely.

Purpose of the Study:

  • To systematically review and estimate the pooled frequency of tremor in people with MS.
  • To provide reliable estimates of tremor prevalence for clinical and research purposes.

Main Methods:

  • A systematic search was conducted across major databases (PubMed/MEDLINE, Embase, Scopus, Web of Science) up to April 27, 2024.
  • 14 studies involving 17,458 PwMS were included in the meta-proportion analysis.
  • A random-effects model was used to calculate the pooled tremor frequency and its 95% confidence interval (CI).

Main Results:

  • The overall pooled frequency of tremor in PwMS was 33.32% (95% CI: 23.47%–44.88%).
  • Tremor prevalence was significantly lower in studies with over 200 participants (22.46%) compared to those with fewer than 200 participants (47.65%).
  • High heterogeneity was observed across studies (I² = 98%).

Conclusions:

  • Tremor is a highly prevalent symptom experienced by a significant proportion of people with MS.
  • The findings underscore the importance of developing and implementing targeted interventions for tremor management in PwMS.
  • Further research may be needed to explore factors contributing to the heterogeneity in tremor prevalence estimates.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
334
Muscle Stimulation Frequency01:22

Muscle Stimulation Frequency

The contraction strength of muscles is regulated by motor neurons, which modulate the frequency of action potentials dispatched to the motor units based on the body's requirements. This process of varying the muscle stimulation frequency allows muscles to contract with a force that is precisely tailored to the needs of the moment, whether lifting a feather or a heavy box.
Wave summation
At low firing rates, motor neurons induce individual twitch contractions in muscle fibers. These twitches...
1.9K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
158
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
832
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
996
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
559